Molecular and physiological characterization of fluoroquinolone resistance in relation to uropathogenicity among Escherichia coli isolates isolated from Wenyu River, China

Chemosphere

Volumn 87, Issue 1, 2012, Pages 37-42

  Sun, Jianxian ^a   Hu, Jianying ^a   Peng, Hui ^a   Shi, Jiachen ^a   Dong, Zhaomin ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Escherichia coli; Fluoroquinolone; Mutation points; Resistance; Uropathogenic; Virulence factors

Indexed keywords

ELECTRIC RESISTANCE; MICROWAVE INTEGRATED CIRCUITS;

FLUOROQUINOLONES; HUMAN RISKS; MINIMUM INHIBITORY CONCENTRATION; MUTATION POINTS; POTENTIAL RISKS; QUINOLONES; UROPATHOGENIC; VIRULENCE FACTORS;

ESCHERICHIA COLI;

QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; FECAL COLIFORM; HEALTH RISK; INHIBITOR; MOLECULAR ANALYSIS; MUTATION; PATHOGENICITY; PHYSIOLOGY; PUBLIC HEALTH; RISK ASSESSMENT; VIRULENCE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MUTATION; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CHINA; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RIVER; UROPATHOGENIC ESCHERICHIA COLI;

BEIJING [CHINA]; CHINA; WENYU RIVER;

ESCHERICHIA COLI;

EID: 84856778965     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2011.11.050     Document Type: Article

References (40)

1. Birosova E., Siegfried L., Kmet'ova M., Makara A., Ostro A., Gresova A., Urdzik P., Liptakova A., Molokacova M., Bartl R., Valansky L. Detection of virulence factors in alpha-haemolytic Escherichia coli strains isolated from various clinical materials. Clin. Microbiol. Infec. 2004, 10:569-573.
2. Boyd L.B., Maynard M.J., Morgan-Linnell S.K., Horton L.B., Sucgang R., Hamill R.J., Jimenez J.R., Versalovic J., Steffen D., Zechiedrich L. Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolates. Antimicrob. Agents Ch. 2009, 53:229-234.
3. CLSI, 2009. Performance standards for antimicrobial susceptibility testing; Nineteenth informational supplement. Clinical and laboratory standards institute (National committee for clinical laboratory standards), wayne, PA.
4. Delorenzo V., Martinez J.L. Aerobactin production as a virulence factor: a reevaluation. Eur. J. Clin. Microbiol. Infect. Dis. 1988, 7:621-629.
5. Duong H.A., Pham N.H., Nguyen H.T., Hoang T.T., Pham H.V., Pham V.C., Berg M., Giger W., Alder A.C. Occurrence, fate and antibiotic resistance of fluoroquinolone antibacterials in hospital wastewaters in Hanoi, Vietnam. Chemosphere 2008, 72:968-973.
6. Ena J., Lopez-Perezagua M.D., Martinez-Peinado C., Cia-Barrio A.D., Ruiz-Lopez I. Emergence of ciprofloxacin resistance in Escherichia coli isolates after widespread use of fluoroquinolones. Diagn. Micr. Infec. Dis. 1998, 30:103-107.
7. Everett M.J., Jin Y.F., Ricci V., Piddock L. Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob. Agents Ch. 1996, 40:2380-2386.
8. Fischbach M.A., Walsh C.T. Antibiotics for emerging pathogens. Science 2009, 325:1089-1093.
9. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am. J. Med. 2003, 49:53-70.
10. Goettsch W., van Pelt W., Nagelkerke N., Hendrix M., Buiting A., Petit P.L., Sabbe L., van Griethuysen A., de Neeling A.J. Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands. J. Antimicrob. Chemoth. 2000, 46:223-228.
11. Hamelin K., Bruant G., El-Shaarawi A., Hill S., Edge T.A., Bekal S., Fairbrother J.M., Harel J., Maynard C., Masson L., Brousseau R. A virulence and antimicrobial resistance DNA microarray detects a high frequency of virulence genes in Escherichia coli isolates from Great Lakes recreational waters. Appl. Environ. Microb. 2006, 72:4200-4206.
12. Hamelin K., Bruant G., El-Shaarawi A., Hill S., Edge T.A., Fairbrother J., Harel J., Maynard C., Masson L., Brousseau R. Occurrence of virulence and antimicrobial resistance genes in Escherichia coli isolates from different aquatic ecosystems within the St. Clair River and Detroit River areas. Appl. Environ. Microb. 2007, 73:477-484.
13. Hooper D.C. Clinical applications of quinolones. Biochim. Biophys. Acta 1998, 1400:45-61.
14. Hu J.Y., Shi J.C., Chang H., Li D., Yang M., Kamagata Y.C. Phenotyping and genotyping of antihiotic-resistant Escherichia coli isolated from a natural river basin. Environ. Sci. Technol. 2008, 42:3415-3420.
15. Johnson J.R. Virulence factors in Escherichia coli urinary tract infection. Clin. Microbiol. Rev. 1991, 4:80-128.
16. Kahlmeter G. The ECO (SENS project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens-interim report. J. Antimicrob. Chemoth. 2000, 46(Suppl. 1):15-22.
17. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECOSENS project. J. Antimicrob. Chemoth. 2003, 51:69-76.
18. Lindgren P.K., Karlsson A., Hughes D. Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob. Agents Ch. 2003, 47:3222-3232.
19. Lu T., Zhao X.L., Drlica K. Gatifloxacin activity against quinolone-resistant gyrase: allele-specific enhancement of bacteriostatic and bactericidal activities by the c-8-methoxy group. Antimicrob. Agents Ch. 1999, 43:2969-2974.
20. Madurga S., Sanchez-Cespedes J., Belda I., Vila J., Giralt E. Mechanism of binding of fluoroquinolones to the quinolone resistance-determining region of DNA gyrase: towards an understanding of the molecular basis of quinolone resistance. Chembiochem 2008, 9:2081-2086.
21. Molbak K., Baggesen D.L., Aarestrup F.M., Ebbesen J.M., Engberg J., Frydendahl K., Gerner-Smidt P., Petersen A.M., Wegener H.C. An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype Typhimurium DT104. New Engl. J. Med. 1999, 341:1420-1425.
22. Munir M., Wong K., Xagoraraki I. Release of antibiotic resistant bacteria and genes in the effluent and biosolids of five wastewater utilities in Michigan. Water Res. 2011, 45:681-693.
23. Nakata H., Kannan K., Jones P.D., Giesy J.P. Determination of fluoroquinolone antibiotics in wastewater effluents by liquid chromatography-mass spectrometry and fluorescence detection. Chemosphere 2005, 58:759-766.
24. Parveen S., Murphree R.L., Edmiston L., Kaspar C.W., Portier K.M., Tamplin M.L. Association of multiple-antibiotic-resistance profiles with point and nonpoint sources of Escherichia coli in Apalachicola Bay. Appl. Environ. Microb. 1997, 63:2607-2612.
25. Picard B., Garcia J.S., Gouriou S., Duriez P., Brahimi N., Bingen E., Elion J., Denamur E. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect. Immun. 1999, 67:546-553.
26. Reinthaler F.F., Posch J., Feierl G., Wust G., Haas D., Ruckenbauer G., Mascher F., Marth E. Antibiotic resistance of E Coli in sewage and sludge. Water Res. 2003, 37:1685-1690.
27. Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J. Antimicrob. Chemoth. 2003, 51:1109-1117.
28. Russo T.A., Johnson J.R. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect. 2003, 5:449-456.
29. Sabate M., Prats G., Moreno E., Balleste E., Blanch A.R., Andreu A. Virulence and antimicrobial resistance profiles among Escherichia coli strains isolated from human and animal wastewater. Res. Microbiol. 2008, 159:288-293.
30. Schmidt C.W. Antibiotic resistance in livestock: more at stake than steak. Environ. Health Persp. 2002, 110:A396-A402.
31. Talan D.A., Stamm W.E., Hooton T.M., Moran G.J., Burke T., Iravani A., Reuning-Scherer J., Church D.A. Comparison of ciprofloxacin (7days) and trimethoprim-sulfamethoxazole (14days) for acute uncomplicated pyelonephritis in women - a randomized trial. J. Am. Med. Assoc. 2000, 283:1583-1590.
32. Teuber M. Veterinary use and antibiotic resistance. Curr. Opin. Microbiol. 2001, 4:493-499.
33. Vila J., Ruiz J., Marco F., Barcelo A., Goni P., Giralt E., Deanta T.J. Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs. Antimicrob. Agents Ch. 1994, 38:2477-2479.
34. Vila J., Ruiz J., Goni P., DeAnta M. Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrob. Agents Ch. 1996, 40:491-493.
35. Wandersman C., Delepelaire P. Bacterial iron sources: from siderophores to hemophores. Annu. Rev. Microbiol. 2004, 58:611-647.
36. Wang H., Dzink-Fox J.L., Chen M.J., Levy S.B. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrob. Agents Ch. 2001, 45:1515-1521.
37. Whitlock J.E., Jones D.T., Harwood V.J. Identification of the sources of fecal coliforms in an urban watershed using antibiotic resistance analysis. Water Res. 2002, 36:4273-4282.
38. Xiao Y., Chang H., Jia A., Hu J.Y. Trace analysis of quinolone and fluoroquinolone antibiotics from wastewaters by liquid chromatography-electrospray tandem mass spectrometry. J. Chromatogr. A 2008, 1214:100-108.
39. Yamamoto S., Terai A., Yuri K., Kurazono H., Taeda Y., Yoshida O. Detection of urovirulence factors in Escherichia coli by multiplex polymerase chain reaction. FEMS Immunol. Med. Microbiol. 1995, 12:85-90.
40. Yoshida H., Bogaki M., Nakamura M., Nakamura S. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Ch. 1990, 34:1271-1272.